Literature DB >> 11083662

Short-term exposure to membrane-active antibiotics inhibits Cryptosporidium parvum infection in cell culture.

A Giacometti1, O Cirioni, M S Del Prete, F Barchiesi, G Scalise.   

Abstract

A cell culture system and double fluorogenic staining were used to study the susceptibility of Cryptosporidium parvum to membrane-active antibiotics. Buforin II and magainin II exerted a cytotoxic effect on sporozoites but did not consistently affect oocyst viability. Lasalocid and nigericin demonstrated less activity against sporozoites but reduced the infectivity of oocysts.

Entities:  

Mesh：

Substances：

Year:  2000        PMID： 11083662      PMCID： PMC90227          DOI： 10.1128/AAC.44.12.3473-3475.2000

Source DB:  PubMed          Journal:  Antimicrob Agents Chemother        ISSN： 0066-4804            Impact factor:   5.191


  14 in total

Review 1.  Peptide antibiotics.

Authors:  R E Hancock; D S Chapple
Journal:  Antimicrob Agents Chemother       Date:  1999-06       Impact factor: 5.191

2.  Anticryptosporidial activity of ranalexin, lasalocid and azithromycin alone and in combination in cell lines.

Authors:  A Giacometti; O Cirioni; F Barchiesi; G Scalise
Journal:  J Antimicrob Chemother       Date:  2000-03       Impact factor: 5.790

3.  In vitro anticryptosporidial activity of dinitroaniline herbicides.

Authors:  M J Arrowood; J R Mead; L Xie; X You
Journal:  FEMS Microbiol Lett       Date:  1996-03-01       Impact factor: 2.742

Review 4.  Peptide antibiotics.

Authors:  R E Hancock
Journal:  Lancet       Date:  1997-02-08       Impact factor: 79.321

5.  Cryptosporidium parvum apical complex glycoprotein CSL contains a sporozoite ligand for intestinal epithelial cells.

Authors:  R C Langer; M W Riggs
Journal:  Infect Immun       Date:  1999-10       Impact factor: 3.441

6.  All-D amino acid-containing channel-forming antibiotic peptides.

Authors:  D Wade; A Boman; B Wåhlin; C M Drain; D Andreu; H G Boman; R B Merrifield
Journal:  Proc Natl Acad Sci U S A       Date:  1990-06       Impact factor: 11.205

7.  Efficacy of lasalocid against murine Pneumocystis carinii pneumonitis.

Authors:  H S OZ; W T Hughes; J E Rehg
Journal:  Antimicrob Agents Chemother       Date:  1997-01       Impact factor: 5.191

8.  Lasalocid-catalyzed proton conductance in Streptococcus bovis as affected by extracellular potassium.

Authors:  W R Schwingel; D B Bates; S C Denham; D K Beede
Journal:  Appl Environ Microbiol       Date:  1989-01       Impact factor: 4.792

9.  Cryptosporidium parvum infection of intestinal epithelium: morphologic and functional studies in an in vitro model.

Authors:  R B Adams; R L Guerrant; S Zu; G Fang; J K Roche
Journal:  J Infect Dis       Date:  1994-01       Impact factor: 5.226

10.  A simple and reliable method of producing in vitro infections of Cryptosporidium parvum (Apicomplexa).

Authors:  S J Upton; M Tilley; M V Nesterenko; D B Brillhart
Journal:  FEMS Microbiol Lett       Date:  1994-05-01       Impact factor: 2.742
View more
  5 in total

1.  Role of positional hydrophobicity in the leishmanicidal activity of magainin 2.

Authors:  Esther Guerrero; José María Saugar; Katsumi Matsuzaki; Luis Rivas
Journal:  Antimicrob Agents Chemother       Date:  2004-08       Impact factor: 5.191

2.  Which prosthesis is more resistant to vascular graft infection: polytetrafluoroethylene or Omniflow II biosynthetic grafts?

Authors:  Orhan Bozoglan; Bulent Mese; Erdinc Eroglu; Serdal Elveren; Mustafa Gul; Ahmet Celik; Halil Ibrahim Yildirimdemir; Harun Ciralik; Alptekin Yasim
Journal:  Surg Today       Date:  2015-03-06       Impact factor: 2.549

3.  An Irish perspective on Cryptosporidium. Part 2.

Authors:  Annetta Zintl; Grace Mulcahy; Theo de Waal; Valerie de Waele; Catherine Byrne; Marguerite Clyne; Nicholas Holden; Seamus Fanning
Journal:  Ir Vet J       Date:  2006-09-01       Impact factor: 2.146

4.  Cathelicidin-like helminth defence molecules (HDMs): absence of cytotoxic, anti-microbial and anti-protozoan activities imply a specific adaptation to immune modulation.

Authors:  Karine Thivierge; Sophie Cotton; Deborah A Schaefer; Michael W Riggs; Joyce To; Maria E Lund; Mark W Robinson; John P Dalton; Sheila M Donnelly
Journal:  PLoS Negl Trop Dis       Date:  2013-07-11

5.  Vascular graft infection by Staphylococcus aureus: efficacy of linezolid, teicoplanin and vancomycin systemic prophylaxis protocols in a rat model.

Authors:  E Atahan; N Katrancioglu; Y Oztop; E Tuncer; H Ozer; S Manduz; E Engin; T D Yalta; O Berkan; K Dogan
Journal:  Cardiovasc J Afr       Date:  2009 Mar-Apr       Impact factor: 1.167
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.